Publicacions més Rellevants:

• J. Costa-Font i E. Mossialos (2005), "Are perceptions of risks and benefits of genetically modified food (in)dependent?", Food Quality and Preference (en premsa).

• J. Costa-Font i E. Mossialos (2005), "The Public as a Limit to Technology Transfer: The influence of Knowledge and Beliefs in Attitudes towards Biotechnology in the UK", Journal of Technology Transfer (en premsa).

• J. Costa-Font i E. Mossialos (2005), "Is Dread of Genetically Modified Food Associated with the Consumers Demand for Information?", Applied Economics Letters 12: 859-863.

• J. Costa-Font, E. Mossialos i M. Costa (2005), "‘Erring on the Side of Caution?’ The Heterogeneity of Public Perceptions Biotechnology Applications in the European Union", Journal of Economics Issues (en premsa).

• J. Costa-Font i J. Rovira (2005), "When do Smokers ‘Underestimate’ Smoking Related Mortality Risks?", Applied Economics Letters 12: 789-794.

• M. Vilella-Vila, J. Costa-Font i E. Mossialos (2005), "Consumer Involvement and Acceptance of Biotechnology in the European Union: a specific focus on Spain and the United Kingdom", International Journal of Consumer Studies 29(2): 108-118.

• J. Costa-Font i E. Mossialos (2005), "‘Ambivalent’ Individual Preferences towards Biotechnology in the European Union: Products or Processes?", Journal of Risk Research 8(4): 341-354.

• J. Costa-Font  i E. Mossialos (2002), "Trusting the public for science policy making? Perceptions of risks in biotechnology applications in the European Union", Pharmaceuticals Policy and Law, 5: 167-183.

• F. Antoñanzas, I. Carvalho, J. Costa-Font , J. Rovira i K. Viscusi (2000), "Smoking risks in Spain (Part II). Perceptions of environmental tobacco smoke externalities", Journal of Risk and Uncertainty, 21: 187-212.

• J. Costa-Font i E. Mossialos (2006), "Which policies effectively enable smoking cesation? Evidence from the European Union", International Journal of Social Economics 33(1): 77-100.

• J. Costa-Font i J. Rovira (2005), "Why some people go private and others do not: supplementary health insurance in Spain", Public Finance and Management 5(4): 523-543.

• P. Kanavos i J. Costa-Font (2005), "Pharmaceutical parallel trade in Europe: stakeholder and competition effects", Economic Policy 44: 752-798.

• J. Costa-Font i J. Gil (2005), "Obesity and the incidence of chronic diseases: a seemingly unrelated probit approach", Economics and Human Biology, forthcoming.

• J. Costa-Font i J. Rovira (2005), "Eliciting Preferences for Collectively Financed Health Programmes: the ‘Willingness to Assign’ Approach", Applied Economics 37: 1571-1583.

• G. Lopez-Casasnovas, J. Costa-Font i I. Planas (2005), "Diversity and regional inequalities: assessing the outcomes of the Spanish 'system of health care services'", Health Economics 14: S221-S235.

• J. Costa-Font i J. Puig-Junoy (2005), "The Pharmaceutical Market Regulation in Spain Is Drug Cost-Containment Under Question?", Journal of Pharmaceuticals Finance, Economics and Policy, 13 (4): 33-49.

• A. Rico i J. Costa-Font (2005), "Power Rather than Path? The Dynamics of Institutional Change under Health Care Federalism", Journal of Health Politics, Policy & Law 30(1-2): 231-252.

• J. Costa-Font (2005), "Inequalities in self reported health within Spanish Regional Health Services: devolution re-examined?", International Journal of Health Planning and Management 20(1): 41-52.

• J. Costa-Font i C. Patxot (2005), "The design of the long-term care system in Spain: policy and financial constraints", Social Policy & Society, 4(1): 11-20.

• E. Mossialos, J. Costa-Font, K. Davaki i K. Karras (2005), "Is there ‘Patient selection’ in the demand for private maternity care in Greece?", Applied Economic Letters 12 (1): 7-12.

• J. Costa-Font i J. Gil (2004), "Social interactions and the contemporaneous determinants of individuals weight", Applied Economics, 36 (20): 253-263.

• J. Costa-Font i C. Patxot (2004), "The intergenerational impact of long-term care financing alternatives in Spain", The Geneva Papers of Risk and Insurance, 29 (4): 599-620.

• J. Costa-Font i M. Font-Vilalta (2004), "Preference for National health service use, captive preferences and the demand for private health insurance in Spain", The Geneva Papers of Risk and Insurance, 29 (4): 706-719.

• J. Darba i E. Albacar (2004), "A framework for handling uncertainty and variability in the economic evaluation of health care programs", Value in Health 7 (6): 768-768.

• J. Costa-Font i J. Garcia (2003), "Measuring socioeconomic health inequalities: fiction or reality?", International Journal of Social Economics, 30 (8): 883-892.

• J. Costa-Font i J. Garcia (2003), "Demand for private health insurance: how important is the quality gap", Health Economics, 12: 587-599.

• J. Darbà (2003), “Pharmaceutical expenditure in Spain. Evolution and cost containment measures during 1998-2001”, European Journal Health Economics 4: 151-157.

• J. Darbà (2003), “Pharmaceutical expenditure and therapeutic value of new medicines in Spain”, Pharmacoeconomics 21 (16):1211-1212.

• Richard G. Halliday i J. Darba (2003), “Cost data assessment in multinational economic evaluations: some theory and review of published studies”, Applied health economics and health policy 2 (3): 149-155.

• J. Gil i E. Gracia (2002), "A comparison of the USA health care effort with other OECD countries", Hacienda Pública Española/Revista de Economía Pública, 161 (2/2002): 31-48.